Johnson & Johnson SIMPONI / SIMPONI ARIA — Percent Change (as a percent) decreased by 105.2% to -1.7% in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 109.0%, from 18.9% to -1.7%. This decline may warrant attention — for this metric, higher values are generally preferred.
Positive growth indicates expanding market share or increased patient utilization, whereas negative growth suggests potential market saturation or competitive pressure.
This metric measures the period-over-period percentage growth or decline in net sales for the Simponi and Simponi Aria p...
Comparable to year-over-year or quarter-over-quarter revenue growth rates for specific pharmaceutical products across the industry.
jnj_segment_simponi_simponi_aria_percent_change_as_a_percent| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 6.9% | -3.3% | 1.5% | -3% | -4.6% | -2% | -5.8% | -6.6% | 15.3% | 3% | 1.6% | -18% | 18.9% | 28.6% | 32.9% | -1.7% |
| QoQ Change | — | -147.8% | +145.5% | -300.0% | -53.3% | +56.5% | -190.0% | -13.8% | +331.8% | -80.4% | -46.7% | <-999% | +205.0% | +51.3% | +15.0% | -105.2% |
| YoY Change | — | — | — | -143.5% | -39.4% | — | -486.7% | -120.0% | +432.6% | +151.7% | +124.2% | -217.6% | +530.0% | >999% | +282.8% | -109.0% |